| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is demonstrating significant advancements in product and service development, particularly in the area of obesity treatments, with a strong focus on drug development and promising clinical results. The company's strategy includes diversifying its growth avenues and expanding its portfolio through partnerships, which bodes well for future prospects. A rising demand for innovative medications further supports Eli Lilly’s growth potential in the competitive biopharma landscape. However, challenges remain in navigating regulatory approvals and potential market competition. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 1.5 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.5, and the negative at 0 on 2025-11-12. The forces of Sentiment towards Fundamentals (3.3), Valuation Sentiment (3.1), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | 0%(0%) | 1 | 0.25% | 1.5 | 3.3 | -4.5 | |||||||
| 2025-11-11 | 0%(0%) | 1 | 0.25% | 1.4 | 4 | 7 | |||||||
| 2025-11-10 | 0%(0%) | 1 | 0.25% | 1 | 3.8 | 5.5 | |||||||
| 2025-11-09 | 0%(0%) | 1 | 0.25% | 1.1 | 3.8 | 7 | |||||||
| 2025-11-08 | 0%(0%) | 1 | 0.25% | 1.1 | 3.8 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 1 | 0.25% | 0.9 | 3.7 | 6 | |||||||
| 2025-11-06 | 0%(0%) | 1 | 0.25% | 0.9 | 3.9 | 0.3 | |||||||
| 2025-11-05 | 0%(0.1%) | 1 | 0.25% | 1 | 4.7 | -1 | |||||||
| 2025-11-04 | 0%(0.1%) | 1 | 0.25% | 1 | 4.7 | 5.3 | |||||||
| 2025-11-03 | 0%(0.1%) | 1 | 0.25% | 1.1 | 4.8 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-12 17:02:31 Articles discuss the regulatory environment and pricing strategies that could pose challenges for Eli Lilly within the pharmaceutical sector. |
| 2025-11-12 17:02:31 The competition in the obesity drug market is noted as a factor that could impact Eli Lilly's market share and stock viability. |
| 2025-11-12 17:02:31 Articles reflect on Eli Lilly's recent earnings and financial health, indicating a positive outlook and future growth potential. |
| 2025-11-12 17:02:31 The company's partnerships, particularly with MeiraGTx, showcase Eli Lilly's strategic moves to enhance its technological capabilities and market position. |
| 2025-11-12 17:02:31 Several articles highlight the strong recent performance of Eli Lilly's stock, marking gains and positive market sentiment. |
| 2025-11-12 09:37:16 Eli Lilly's shift to Rightway for its drug benefit plan indicates strategic adjustments in partnerships for better employee health management. |
| 2025-11-12 09:37:16 Novo Nordisk's actions to cut Wegovy prices in India are a direct response to maintain market share against Eli Lilly, indicating aggressive competitive tactics in the sector. |
| 2025-11-12 09:37:16 Eli Lilly's decision to drop CVS Health’s drug benefit plan highlights the competitive dynamics in the pharmaceutical industry, particularly in the obesity drug market. |